Korean Circ J.
2011 Sep;41(9):546-548. 10.4070/kcj.2011.41.9.546.
Acute Cerebral Infarction Following Intravenous Glycoprotein IIb/IIIa Inhibitor for Acute Myocardial Infarction
- Affiliations
-
- 1Department of Cardiology, Konkuk University School of Medicine, Chungju Hospital, Chungju, Korea. gilll@paran.com
- 2Department of Neurology, Konkuk University School of Medicine, Chungju Hospital, Chungju, Korea.
- KMID: 2094108
- DOI: http://doi.org/10.4070/kcj.2011.41.9.546
Abstract
- Stroke is a rare but serious complication of acute myocardial infarction (AMI). Currently, glycoprotein (GP) IIb/IIIa inhibitor is used in clinical practice for acute coronary syndromes and percutaneous coronary interventions (PCIs). The incidence of stroke in patients receiving GP IIb/IIIa inhibitor during PCIs is very low. We report the case of a 47-year-old man who presented with AMI and suffered an acute cerebral infarction after infusion of a GP IIb/IIIa inhibitor following primary PCI.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Clinical outcome in elderly patients older than 70 years with acute myocardial infarction after use of platelet glycoprotein IIb/IIIa receptor blocker during percutaneous coronary intervention: Comparison with those younger than 70 years
- Acute Stent Thrombosis after Coronary Stenting in Patients with Acute Coronary Syndrome
- A Case of the Thrombi in Left Atrial Appendage Confirmed by Transesophageal Echocardiography(TEE) in A Patient with Acute Myocardial Infarction Accompanied by Cerebral Infarction
- Invasive Treatment of Acute Myocardial Infarction: What is the Optimal Therapy for Acute Myocardial Infarction?
- Primary Coronary Stenting as a Successful Treatment of Acute Myocardial
